Cambridge, MA (PRWEB) November 3, 2006
Akaza Research is pleased to announce that over 3,000 copies of the OpenClinica open source clinical trial software have been downloaded since OpenClinica was fist made publicly available less than one year ago. In its fist six months publicly available, OpenClinica received approximately 1,000 downloads. In its second six months this number doubled to over 2,000, for a total of over 3,000 downloads to date.
"The growth of interest and activity surrounding OpenClinica is accelerating," said Benjamin Baumann, Akaza's Director of Business Development. "This not only validates the collective power of the open source community, but underscores the need for an open source solution in the clinical trials space," he added.
Most alternative software packages are proprietary, rigid and carry steep recurring fees that can easily run into the hundreds of thousands of dollars. OpenClinica takes a dramatically different approach. As an open source application it is available for free and can easily be modified and integrated with other clinical informatics systems. Its Java J2EE architecture provides a secure, robust and extensible system for managing multiple clinical research studies within a centralized repository. OpenClinica supports leading industry standards, including CDISC, to support best practices and enable interoperability with other systems and data sources.
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage multi-site clinical studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a standards-based, extensible, and modular platform. OpenClinica v1.0 was released in late 2005 under the GNU Lesser General Public License (LGPL). See http://www.OpenClinica.org.
About Akaza Research, LLC
Akaza Research is a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software. Akaza is bringing Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based solutions accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.